Boothbay Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Sell |
530
-146
| -22% | -$65K | ﹤0.01% | 1001 |
|
|
2025
Q1 | $328K | Buy |
+676
| New | +$328K | 0.01% | 875 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1722 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1740 |
|
|
2022
Q3 | – | Sell |
-5,323
| Closed | -$1.5M | – | 2321 |
|
|
2022
Q2 | $1.5M | Buy |
5,323
+2,175
| +69% | +$613K | 0.04% | 589 |
|
|
2022
Q1 | $822K | Sell |
3,148
-10,273
| -77% | -$2.68M | 0.02% | 823 |
|
|
2021
Q4 | $2.95M | Buy |
13,421
+635
| +5% | +$139K | 0.07% | 290 |
|
|
2021
Q3 | $2.32M | Sell |
12,786
-1,371
| -10% | -$249K | 0.06% | 310 |
|
|
2021
Q2 | $2.85M | Buy |
14,157
+4,711
| +50% | +$950K | 0.09% | 218 |
|
|
2021
Q1 | $2.03M | Buy |
9,446
+3,213
| +52% | +$690K | 0.08% | 246 |
|
|
2020
Q4 | $1.47M | Buy |
+6,233
| New | +$1.47M | 0.05% | 291 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 814 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 806 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 818 |
|
|
2018
Q3 | – | Sell |
-1,282
| Closed | -$218K | – | 840 |
|
|
2018
Q2 | $218K | Sell |
1,282
-871
| -40% | -$148K | 0.02% | 473 |
|
|
2018
Q1 | $351K | Buy |
2,153
+413
| +24% | +$67.3K | 0.04% | 317 |
|
|
2017
Q4 | $261K | Sell |
1,740
-1,072
| -38% | -$161K | 0.04% | 412 |
|
|
2017
Q3 | $428K | Buy |
+2,812
| New | +$428K | 0.07% | 238 |
|
|
2017
Q2 | – | Sell |
-5,059
| Closed | -$553K | – | 776 |
|
|
2017
Q1 | $553K | Buy |
+5,059
| New | +$553K | 0.1% | 186 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 737 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 564 |
|